Towards Healthcare
Neurodiagnostics Market
Updated Date: 11 March 2026   |   Report Code: 6745

Neurodiagnostics Market Addressing Patient Access, Affordability, and Health Equity Issues in Diagnostics

Based on our market research, the neurodiagnostics market was valued at USD 19.05 billion in 2025 and is projected to grow from USD 20.68 billion in 2026 to USD 43.27 billion by 2035, expanding at a CAGR of 8.55% during 2026–2035

Last Updated : 11 March 2026 Category: Diagnostics Insight Code: 6745 Format: PDF / PPT / Excel

Executive Summary

1.1 Market Overview and Key Drivers
1.2 Emerging Trends and Innovations in Neurodiagnostics
1.3 Competitive Landscape and Positioning of Key Industry Players
1.4 Key Challenges and Opportunities in the Neurodiagnostics Market
1.5 Strategic Insights and Recommendations from Industry Experts

Introduction

2.1 Overview of Neurodiagnostics: Technologies, Applications, and Trends
2.2 Key Industry Dynamics and Shaping Forces in the Neurodiagnostics Market
2.3 Related Reports and Market Intelligence: Insights from Adjacent Markets
2.4 Long-term Outlook and Expected Shifts in the Neurodiagnostics Market

Disease/Technology/Market Overview

3.1 Pathophysiology of Neurological Disorders and Role of Diagnostics
3.2 Technological Evolution in Neurodiagnostic Devices and Techniques
3.3 Key Factors Driving Market Growth or Research in Neurodiagnostics
3.4 Historical Development and Current Trends in Neurodiagnostics
3.5 Diagnostic Approaches: Brain Imaging, EEG, Electromyography, and More

Treatment/Technology Landscape

4.1 Current Diagnostic Modalities: EEG, MRI, CT Scans, and PET Imaging
4.2 Recent Advancements in Neurodiagnostics Technologies (AI Integration, Machine Learning)
4.3 Challenges in Diagnostic Accuracy and Device Adoption in Neurology
4.4 Comparative Analysis of Current and Emerging Neurodiagnostic Solutions
4.5 Physician and Patient Perspectives on Neurodiagnostic Techniques and Devices

Epidemiology/Market Segmentation

5.1 Prevalence and Incidence of Neurological Disorders and Diagnostic Needs
5.2 Geographic Distribution and Demographic Factors Affecting Neurodiagnostic Adoption
5.3 Comorbidities and Adjacent Markets Impacting Neurodiagnostics
5.4 Market by Key Segments: Device Type, Diagnostic Method, Patient Group
5.5 Trends in Healthcare Consumer Behavior and Neurodiagnostic Adoption

Competitive Assessment and Key Players

6.1 Market Leaders and Innovators in the Neurodiagnostic Devices Market
6.2 Competitive Landscape: Strategic Positioning and Key Competitors in the Space
6.3 Emerging Companies and Technologies in Neurodiagnostics to Watch
6.4 Market Share Breakdown by Company, Technology, and Region

Unmet Needs and Strategic Opportunities

7.1 Gaps in Current Neurodiagnostic Offerings and Market Demand
7.2 Opportunities in Personalized Diagnostics for Neurological Disorders
7.3 Regulatory and Reimbursement Challenges in Neurodiagnostics
7.4 Addressing Patient Access, Affordability, and Health Equity Issues in Diagnostics
7.5 Future Opportunities in Market Expansion and Technological Innovation

Regulatory and Market Access Landscape

8.1 Overview of Regulatory Pathways and Challenges in Neurodiagnostics
8.2 Market Access Strategies: Barriers and Opportunities for Entry
8.3 Reimbursement Models and Pricing Pressures in Neurodiagnostic Devices
8.4 Global Regulatory Shifts and Their Impact on Neurodiagnostic Device Development

R&D and Innovation Strategies

9.1 Research and Development Trends in Neurodiagnostics and Brain Monitoring
9.2 Collaborations, Mergers, and Acquisitions Among Key Players in Neurodiagnostics
9.3 Investment Trends and Funding for Innovation in Neurological Diagnostics
9.4 Clinical Trial Design and Development Challenges in Neurodiagnostics
9.5 Breakthrough Technologies and Their Impact on the Neurodiagnostics Market

Strategic Recommendations

10.1 Entry and Expansion Strategies for New Market Players in Neurodiagnostics
10.2 Strategic Recommendations for Industry Leaders in Neurodiagnostic Technologies
10.3 Insights into Mergers, Acquisitions, and Partnerships in the Neurodiagnostics Space
10.4 Innovations and Differentiation Strategies in the Competitive Landscape
10.5 Pricing and Cost Management Strategies for Neurodiagnostic Devices

Future Market Outlook

11.1 Emerging Technologies in Neurodiagnostics and Their Market Potential
11.2 Market Forecast for Neurodiagnostics (X Years) with Key Growth Drivers and Projections
11.3 Impact of Regulatory Changes and Policy Developments on Neurodiagnostics
11.4 Long-term Strategic Trends in Neurology and Neurodiagnostic Devices

Conclusion

12.1 Key Takeaways and Strategic Implications for Stakeholders in Neurodiagnostics
12.2 Future Challenges and Opportunities in the Neurodiagnostics Market

Appendix

13.1 Bibliography
13.2 Abbreviations and Glossary of Terms
13.3 Methodology and Data Sources
13.4 Expert Interviews: Key Opinion Leaders (KOLs) and Stakeholder Insights
13.5 Primary Research and Market Survey Details
13.6 About the Authors and Analyst Team
13.7 Contact Information

FAQ's

Answer : The neurodiagnostics market in 2026 is valued at USD 20.68 billion and is projected to climb to USD 43.27 billion by 2035, with a CAGR of 8.55% over the forecast period.

Answer : North America is dominant in the neurodiagnostics market by 36% due to high disease prevalence and the presence of advanced infrastructure & R&D.

Answer : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar
WhatsApp